Home > Boards > Cryptocurrency > Coins > Bitcoin Cash (BCHUSD)

Microsoft now accepts bitcoin cash. Investors need to

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
septmike09 Member Profile
Member Level 
Followed By 60
Posts 10,350
Boards Moderated 1
Alias Born 01/04/07
160x600 placeholder
STOXX Europe 600 Index Ends 0.37% Higher at 469.96 -- Data Talk
The STOXX Europe 600 Index is up 1.74 points or 0.37% today to 469.96 --A new record close
DAX Ends 0.33% Higher at 15744.67 -- Data Talk
CAC 40 Index Ends 0.52% Higher at 6781.19 -- Data Talk
EURO STOXX 50 Index Ends 0.39% Higher at 4161.08 -- Data Talk
FTSE 100 Index Ends 0.05% Lower at 7120.43 -- Data Talk
STOXX Europe 50 Index Ends 0.35% Higher at 3613.98 -- Data Talk
FTSE 100 Falls as BOE Inflation Forecasts Boost Sterling
Correction to Booking Holdings Swings to 2Q Loss Article on Aug. 4
Top Company News of the Day
Qualcomm Bids $4.6 Billion for Veoneer in Bid to Trump Magna Deal -- Update
Cigna Corporation Down Over 11%, on Pace for Largest Percent Decrease Since March 2020 -- Data Talk
Unemployment Rate Seen Ticking Down to 5.7% -- Data Week Ahead
Mortgage Rates Move Lower in Latest Week, Freddie Mac Says
BHP Group Approves $800 Million Capital Expenditure For Oil Projects in U.S., Mexico
Qualcomm Bids $4.6 Billion for Veoneer in Bid to Trump Magna Deal
Corn Export Sales Higher Than Expectations
NanoVibronix Completes Application Process for Reimbursement Code for UroShield
U.S. Jobless Claims Down 14K to 385K in July 31 Week
Gilead's Kite, Appia Bio to Collaborate on Allogeneic Cell Therapies for Cancer
Exelixis Gets FDA Priority Review of Cabometyx in Differentiated Thyroid Cancer
Bank of England Leaves Interest Rate Unchanged Amid Pandemic Uncertainty -- Update
Eiger BioPharmaceuticals Gets Breakthrough Therapy Designation for Avexitide
Merck: Keytruda Meets Key Endpoint in Stage II Resected Melanoma, Gets Priority Review
Pfizer Accused of Overcharging for Epilepsy Seizure Drug by UK Competition Watchdog -- Update
Regeneron, Sanofi: Libtayo Phase 3 Study Meets Primary Endpoint
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences